Vaccine Research At Bavarian Nordic A/S Pharmaceuticals

An employee processes solutions containing samples taken from hazard suits and clothing to detect evidence of contamination in a laboratory at the Bavarian Nordic A/S biotechnology company, where the research into infectious diseases, including the ebola vaccine, takes place in Kvistgaard, Denmark, on Friday, Oct. 31, 2014. The ebola vaccine combines a shot from Johnson & Johnson's Janssen unit in the Netherlands with one developed by Bavarian Nordic, the U.S.-based company said. Photographer: Freya Ingrid Morales/Bloomberg via Getty Images
An employee processes solutions containing samples taken from hazard suits and clothing to detect evidence of contamination in a laboratory at the Bavarian Nordic A/S biotechnology company, where the research into infectious diseases, including the ebola vaccine, takes place in Kvistgaard, Denmark, on Friday, Oct. 31, 2014. The ebola vaccine combines a shot from Johnson & Johnson's Janssen unit in the Netherlands with one developed by Bavarian Nordic, the U.S.-based company said. Photographer: Freya Ingrid Morales/Bloomberg via Getty Images
Vaccine Research At Bavarian Nordic A/S Pharmaceuticals
PURCHASE A LICENSE
How can I use this image?
$575.00
CAD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
458177034
Collection:
Bloomberg
Date created:
October 31, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
DENMARK PHARMA
Max file size:
4000 x 2667 px (13.33 x 8.89 in) - 300 dpi - 2 MB